Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.11B |
| 2 |
Snowflake
SNOW
|
+$1.67B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 4 |
Shopify
SHOP
|
+$1.42B |
| 5 |
Royalty Pharma
RPRX
|
+$1.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$2.27B |
| 2 |
Amazon
AMZN
|
+$2.09B |
| 3 |
Vipshop
VIPS
|
+$1.28B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.27B |
| 5 |
Alibaba
BABA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.57% |
| 2 | Healthcare | 9.66% |
| 3 | Financials | 8.97% |
| 4 | Communication Services | 8.91% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAVE
2101
DELISTED
Spirit Airlines, Inc.
SAVE
| $16.6M | ﹤0.01% |
450,854
+30,566
| +7% | +$981K |
|
|
MTSC
2102
DELISTED
MTS Systems Corp
MTSC
| $16.6M | ﹤0.01% |
285,670
+88,589
| +45% | +$5.19M |
|
2103
Acadia Pharmaceuticals
ACAD
$4.89B
| $16.6M | ﹤0.01% |
643,050
+133,567
| +26% | +$5.88M |
|
2104
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.59B
| $16.6M | ﹤0.01% |
326,601
-27,075
| -8% | -$1.38M |
|
2105
Universal Health Services
UHS
$10.1B
| $16.6M | ﹤0.01% |
124,330
-2,939
| -2% | -$390K |
|
2106
Wipro
WIT
$19.4B
| $16.6M | ﹤0.01% |
5,226,668
-2,655,414
| -34% | -$8.53M |
|
|
ALE
2107
DELISTED
Allete
ALE
| $16.6M | ﹤0.01% |
246,433
-16,238
| -6% | -$1.06M |
|
2108
United Natural Foods
UNFI
$2.94B
| $16.5M | ﹤0.01% |
502,348
+53,358
| +12% | +$1.49M |
|
2109
Costamare
CMRE
$1.74B
| $16.5M | ﹤0.01% |
1,719,918
+496,589
| +41% | +$4.63M |
|
2110
Azenta
AZTA
$1.49B
| $16.5M | ﹤0.01% |
202,584
-308,556
| -60% | -$24.9M |
|
2111
Ethan Allen Interiors
ETD
$583M
| $16.5M | ﹤0.01% |
598,688
-84,576
| -12% | -$2.13M |
|
|
IHIT
2112
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
| $16.5M | ﹤0.01% |
1,785,448
-55,697
| -3% | -$503K |
|
2113
FormFactor
FORM
$10.3B
| $16.5M | ﹤0.01% |
365,977
+57,548
| +19% | +$2.62M |
|
|
RCM
2114
DELISTED
R1 RCM Inc. Common Stock
RCM
| $16.5M | ﹤0.01% |
668,646
-188,564
| -22% | -$4.98M |
|
2115
Goodyear
GT
$1.78B
| $16.5M | ﹤0.01% |
938,437
-1,873,126
| -67% | -$27.1M |
|
2116
WisdomTree International SmallCap Dividend Fund
DLS
$1.08B
| $16.5M | ﹤0.01% |
227,893
-32,498
| -12% | -$2.3M |
|
2117
Davis Select Financial ETF
DFNL
$495M
| $16.4M | ﹤0.01% |
584,705
-21,610
| -4% | -$567K |
|
|
PKO
2118
DELISTED
Pimco Income Opportunity Fund
PKO
| $16.4M | ﹤0.01% |
623,547
+114,096
| +22% | +$2.92M |
|
2119
ATI
ATI
$30.9B
| $16.4M | ﹤0.01% |
778,324
-105,094
| -12% | -$2.05M |
|
2120
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$619M
| $16.4M | ﹤0.01% |
317,945
+45,757
| +17% | +$2.37M |
|
2121
Ashland
ASH
$3.36B
| $16.4M | ﹤0.01% |
184,527
+70,746
| +62% | +$6.1M |
|
2122
Prestige Consumer Healthcare
PBH
$2.43B
| $16.4M | ﹤0.01% |
371,621
+159,636
| +75% | +$6.71M |
|
2123
iShares Morningstar Value ETF
ILCV
$1.36B
| $16.4M | ﹤0.01% |
266,618
-26,616
| -9% | -$1.56M |
|
|
EPZM
2124
DELISTED
Epizyme, Inc
EPZM
| $16.4M | ﹤0.01% |
1,879,041
+9,795
| +0.5% | +$101K |
|
2125
Cytokinetics
CYTK
$10.2B
| $16.4M | ﹤0.01% |
703,217
-191,460
| -21% | -$4.09M |
|
Similar funds
Morgan Stanley's Q1 2021 Portfolio in Review
As of Q1 2021, Morgan Stanley held 7,749 positions worth $681B, up 5.1% from $647B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2021 filing shows 618 new, 3,173 increased, 3,213 reduced and 189 closed positions. Its largest new stake was Coupang: 16,573,913 shares worth $818M. The largest sale was Paramount Global Class B, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2021 buy was Coupang: 16,573,913 shares worth $818M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $3.11B increase.
- Morgan Stanley's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $2.27B.
- Morgan Stanley fully exited Tiffany & Co. in Q1 2021, selling an estimated $318M.
- Morgan Stanley's ten largest holdings make up 16% of its $681B portfolio in Q1 2021.
- Morgan Stanley opened 618 new positions and closed 189 in Q1 2021.
- Morgan Stanley's portfolio value rose 5.1% quarter-over-quarter to $681B.
Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.